September 3rd 2025
Digital solutions help pharmaceutical manufacturers navigate the complex supply chain.
Cleaning Limits—Why the 10-ppm Criterion should be Abandoned
January 2nd 2016The 10-ppm criterion for the acceptable concentration of potential API in cleaning validation to minimize cross contamination into next product has been employed for many years. This article describes why the 10-ppm criterion, which was established based on analytical limitations and estimates of acceptability, is no longer necessary and why a risk-based approach should be universally adopted.
Catalent Secures Manufacturing Contract for Pfizer’s OTC Heartburn Treatment
December 7th 2015Catalent has entered into an exclusive long-term supply agreement to produce Pfizer’s OTC proton-pump inhibitor for heartburn treatment, Nexium 24HR (esomeprazole), which is also marketed as Nexium Control outside the US.